Familial frontotemporal dementia and amyotrophic lateral sclerosis associated with the C9ORF72 hexanucleotide repeat

Brain

Volumn 135, Issue 3, 2012, Pages 652-655

  Hodges, John ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN; TAR DNA BINDING PROTEIN; TAU PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; APHASIA; BRAIN REGION; CHROMOSOME 9; DELUSIONAL DISORDER; DEMENTIA; DISEASE DURATION; FAMILIAL FRONTOTEMPORAL DEMENTIA; FAMILY HISTORY; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC LINKAGE; HUMAN; INTRON; NOTE; NUCLEOTIDE REPEAT; OPEN READING FRAME; PARANOID SCHIZOPHRENIA; PHENOTYPE; PRIORITY JOURNAL; SOMATOFORM DISORDER; SURVIVAL RATE;

EID: 84857612209     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws033     Document Type: Note

References (22)

1. Boeve BF, Boylan KB, Graff-Radford NR, De Jesus-Hernandez M, Knopman DS, Pedraza O, et al. Characterization of Frontotemporal Dementia and/or Amyotrophic Lateral Sclerosis Associated with the GGGGCC Repeat Expansion in C9ORF72. Brain 2012;135.
2. Burrell JR, Kiernan MC, Vucic S, Hodges JR. Motor neuron dysfunction in frontotemporal dementia. Brain 2011;134(Pt 9):2582-94.
3. Chio A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, et al. Clinical characteristics of familial ALS patients carrying the pathogenic GGGGCC hexanucleotide repeat expansion of the C9ORF72 gene. Brain 2012.
4. Cooper-Knock J, Shaw P, Hewitt C, Highley R, Brokington A, Milano A, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 2012;135.
5. De Jesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245-56.
6. Garcin B, Lillo P, Hornberger M, Piguet O, Dawson K, Nestor PJ, et al. Determinants of survival in behavioral variant frontotemporal dementia. Neurology 2009;73:1656-61.
7. Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH, McMonagle P, et al. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 2010;133(Pt 1):300-6.
8. Hsiung GY, De Jesus-Hernandez M, Feldman H, Sengdy P, Bouchard JP, Dwosh E, et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutatoin on Chromosome 9p. Brain 2012;135.
9. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-5.
10. Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol 2010;67:826-30.
11. Luty AA, Kwok JB, Thompson EM, Blumbergs P, Brooks WS, Loy CT, et al. Pedigree with frontotemporal lobar degeneration-motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. BMC Neurol 2008;8:32.
12. Mahoney C, Beck J, Rohrer J, Lashley T, Mok K, Yeatman T, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012;135.
13. Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 2006;66:839-44.
14. Pick A. Senile Hirnatrophie als Gundlage von Hernderscheinunger, Wiener Klinische Wochenschrift. Monatschrift fur Psychiatrie und Neurologie 1901;14:403-4.
15. Pick A. Zur symptomatologie der linksseitigen Schlafenlappenatrophie. Monatschrift fur Psychiatrie und Neurologie 1904;16:378-88.
16. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257-68.
17. Schofield EC, Halliday GM, Kwok J, Loy C, Double KL, Hodges JR. Low serum progranulin predicts the presence of mutations: a prospective study. J Alzheimers Dis 2010;22:981-4.
18. Simon-Sanchez J, Dopper E, Cohn-Hokke P, Hukema R, Nicolaou N, Seelaar H, et al. The clinical and pathological phenotype of C9orf72 hexanucleotide repeat expansions. Brain 2012.
19. Snowden J, Rollinson S, Thompson J, Harris J, Stopford C, Richardson A, et al. Distinct clinical characteristics in patients with frontotemporal dementia and C9ORF72 mutations: a study of demographics, neurology, behaviour, cognition and histopathology. Brain 2012;135.
20. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-41.
21. Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, Sreedharan J, et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain 2006;129(Pt 4):868-76.
22. Whitwell J, Weigand S, Boeve BF, Senjem M, Gunter J, De Jesus-Hernandez M, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 2012;135.